Skip to main content
. Author manuscript; available in PMC: 2017 Apr 8.
Published in final edited form as: Prev Med. 2016 Aug 8;92:36–46. doi: 10.1016/j.ypmed.2016.08.008

Table 1.

Extending the intervention to special populations.

Study Primary trend Additional trends n CM duration (weeks) Maximum earnings Statistically significant treatment effect Included follow up? Statistically significant effects at follow-up Drug of abuse CM target
Alessi and Petry (2014) Special populations Community clinics 45 4 CNBD Yes Yes No Nicotine Abstinence
Businelle et al. (2014) Special populations N/A 68 5 $150 Yes No N/A Nicotine Abstinence
Drummond et al. (2014) Special populations N/A 100 24 $225 Yes No N/A Nicotine Abstinence
Dunn et al. (2010) Special populations Pharmacotherapy 40 2 $362.50 Yes Yes No Nicotine Abstinence
García-Fernández et al. (2013) Special populations N/A 108 24 $2196.00 Yes No N/A Cocaine Abstinence
Hagedorn et al. (2013) Special populations Community clinics 332 8 CNBD Yes Yes No Polydrug Abstinence
Hertzberg et al. (2013) Special populations Technology 22 4 $690 (530 for CM) No N/A N/A Nicotine Abstinence
Higgins et al. (2014) Special populations Parametric questions, longer-term outcomes 130 52 $1180 Yes Yes No Nicotine Abstinence
Holtyn et al. (2014) Special populations N/A 98 30 $6000 Yes Yes No Cocaine/Opioids Abstinence + other therapeutic goal
Kaminer et al. (2014) Special populations N/A 79 7 CNBD No N/A N/A Marijuana Abstinence
Kelly et al. (2014) Special populations Community clinics 160 6 CNBD Yes No N/A Polydrug Other therapeutic goal
Kendzor et al. (2014) Special populations Pharmacotherapy 146 4 $150 Yes Yes Yes Nicotine Abstinence
Kidorf et al. (2013) Special populations Community clinics 125 12 $300.00 Yes No N/A Opioids Other therapeutic goal
Krishnan-Sarin et al. (2013) Special populations N/A 157 4 $262 Yes Yes No Nicotine Abstinence
McDonell et al. (2013) Special populations Community clinics 176 12 CNBD Yes Yes Yes Polydrug Abstinence
Menza et al. (2010) Special populations N/A 127 12 $453.75 No N/A N/A Methamphetamine Abstinence
Ondersma et al. (2012) Special populations Community clinics, parametric, technology 110 10 $50.00 No N/A N/A Nicotine Abstinence
Petry et al. (2010) Special populations Community clinics, parametric 170 24 CNBD Yes Yes No Cocaine/opioids Other therapeutic goal
Petry et al. (2013) Special populations Community clinics 19 8 CNBD Yes No N/A Cocaine Abstinence
Reback et al. (2010) Special populations Community clinics 131 24 CNBD Yes Yes Yes Polydrug Abstinence + other therapeutic goal
Schottenfeld et al. (2011) Special populations Longer-term outcomes 145 24 $935 Yes Yes Yes Cocaine Abstinence
Secades-Villa et al. (2013) Special populations Community clinics 118 24 $2196.00 Yes No N/A Cocaine Abstinence
Stanger et al. (2009) Special populations N/A 69 12 $570 Yes Yes No Marijuana Abstinence

Note: primary trend refers to main trend authors assigned study to; additional trends refers to additional trends study was assigned to aside from the primary trend; n refers to sample size (across all groups); CM duration refers to the number of weeks during which contingent incentives could be earned (CNBD = duration could not be determined); Maximum earnings refers to the maximum amount that could be earned in the intervention (CNBD = maximum earnings could not be determined); Statistically significant treatment effects and effects at follow-up defined in all studies as outcomes significant at p < 0.05; Follow up effects were only evaluated if during treatment effects were statistically significant; drug of abuse refers to drug targeted by CM intervention; CM target refers to the behavior on which incentives were contingent.